Breast Cancer
Presence of inflammatory response indicated poor outcome in breast cancer patients
Published in Women's Health Weekly, April 6th, 2006
"Prediction of outcome in patients with metastatic breast cancer remains problematical. The present study evaluated the value of an inflammation-based prognostic score (Glasgow Prognostic Score, GPS) in patients with metastatic breast cancer," scientists writing in the British Journal of Cancer reported.
"The GPS was constructed as follows: patients with both an elevated C-reactive protein (410 mg/L) and hypoalbuminaemia (<35 g/L) were allocated a score of 2. Patients in whom only one or none of these biochemical abnormalities was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Incidence of BRCA1/BRCA2 mutations in breast cancer patients varies by ethnicity - Diabetes Pathogenesis
Maternal glycemia during pregnancy linked to high birth weight and diabetes risk - Gynecology
Hormone replacement therapy does not affect heart disease/overall mortality in older women - Ischemia
Ischemic heart disease therapy in women should cater to gender-specific differences - Menopause
Menopausal hot flash treatment with nonhormonal therapies are focus of review - Addiction Medicine
Factors correlating to drug abuse treatment initiation were examined - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
